Date published: 2025-9-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

MON1B Inhibitors

MON1B inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of MON1B, a protein that plays a critical role in regulating intracellular membrane trafficking, particularly in endosomal maturation and vesicle transport. MON1B, in complex with CCZ1, is involved in the transition of early endosomes to late endosomes by recruiting and activating Rab7, a key GTPase that governs endosomal maturation and subsequent fusion with lysosomes. This process is essential for the proper sorting of proteins, lipids, and other cargo, as well as for maintaining cellular homeostasis through the degradation and recycling of cellular components. By inhibiting MON1B, researchers can disrupt these critical trafficking pathways, leading to impaired endosome-to-lysosome transport and the accumulation of undegraded materials in cells, thus providing a useful tool to study vesicular transport and its broader implications for cellular function.

In research contexts, MON1B inhibitors are valuable for investigating the molecular mechanisms that underlie endosomal maturation and the broader impact of disrupted vesicle trafficking on cellular processes such as autophagy, nutrient sensing, and organelle maintenance. By blocking MON1B activity, scientists can explore how the inhibition affects endosome-lysosome fusion, cargo degradation, and the recycling of cellular components. This inhibition allows for the examination of how defects in these pathways can lead to cellular dysfunction, including altered metabolic signaling, impaired organelle function, and misregulation of cellular homeostasis. Additionally, MON1B inhibitors provide insights into the interactions between MON1B and other components of the endosomal sorting machinery, helping to elucidate the complex networks that regulate intracellular trafficking. Through these studies, the use of MON1B inhibitors enhances our understanding of the intricate processes involved in vesicle transport, endosome maturation, and the broader implications of these pathways for maintaining cellular health and functionality.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K, potentially altering vesicular trafficking and autophagy processes.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Inhibits dynamin, potentially affecting endocytosis and vesicular trafficking pathways.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Inhibits tyrosine kinases, potentially altering signaling pathways that regulate endosomal function.

FCM Lysing solution (1x)

sc-3621
150 ml
$61.00
8
(1)

Raises lysosomal pH, potentially affecting lysosomal function and related protein trafficking.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Similar to NH4Cl, raises lysosomal pH, potentially affecting lysosomal degradation processes.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Specifically inhibits V-ATPase, potentially affecting acidification of organelles and protein sorting.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

Disrupts Golgi function, potentially affecting glycosylation and trafficking of proteins.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Disrupts microtubule polymerization, potentially affecting vesicular transport processes.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$145.00
$442.00
64
(4)

Inhibits actin polymerization, potentially affecting cytoskeleton-dependent transport and signaling.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

Inhibits CDC42, potentially affecting actin organization and membrane trafficking.